Mettler-Toledo International 과거 수익 실적
과거 기준 확인 2/6
Mettler-Toledo International은 연평균 9.1%의 비율로 수입이 증가해 온 반면, Life Sciences 산업은 연평균 11.7%의 비율로 수입이 증가했습니다. 매출은 연평균 6.1%의 비율로 증가했습니다.
주요 정보
9.1%
수익 성장률
11.8%
EPS 성장률
| Life Sciences 산업 성장 | 21.5% |
| 매출 성장률 | 6.1% |
| 자기자본 수익률 | n/a |
| 순이익 | 21.1% |
| 최근 수익 업데이트 | 30 Sep 2024 |
최근 과거 실적 업데이트
Recent updates
Mettler-Toledo: Disconnect From Economics At More Fair Valuations
Nov 12Should You Investigate Mettler-Toledo International Inc. (NYSE:MTD) At US$1,374?
Oct 20
Mettler-Toledo International Inc.'s (NYSE:MTD) Business Is Trailing The Market But Its Shares Aren't
Aug 27Mettler-Toledo: Continued Excellence In Business Economics And Investment Debate
Aug 06Are Mettler-Toledo International Inc. (NYSE:MTD) Investors Paying Above The Intrinsic Value?
Jul 31Is It Time To Consider Buying Mettler-Toledo International Inc. (NYSE:MTD)?
Jul 04Mettler-Toledo: Putting On A Lot Of Weight
May 22Mettler-Toledo International Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 12Risks To Shareholder Returns Are Elevated At These Prices For Mettler-Toledo International Inc. (NYSE:MTD)
Apr 30Are Mettler-Toledo International Inc. (NYSE:MTD) Investors Paying Above The Intrinsic Value?
Apr 03At US$1,350, Is It Time To Put Mettler-Toledo International Inc. (NYSE:MTD) On Your Watch List?
Mar 08Mettler-Toledo: Strong Cost Control And Pricing Growth Amid Weak Topline Growth
Feb 15What Mettler-Toledo International Inc.'s (NYSE:MTD) P/E Is Not Telling You
Jan 19Mettler-Toledo's 2023 Dip Exposes An Opportunity To Acquire This Compounder At A Discount
Jan 12Are Mettler-Toledo International Inc. (NYSE:MTD) Investors Paying Above The Intrinsic Value?
Dec 29Why Mettler-Toledo International Inc. (NYSE:MTD) Could Be Worth Watching
Dec 08Mettler-Toledo: Weak Chinese Pharma And Biopharma Continues To FY24
Nov 11Mettler-Toledo International (NYSE:MTD) Ticks All The Boxes When It Comes To Earnings Growth
Oct 06Mettler-Toledo: Precision Maker Is Off The Marks
Oct 01Mettler-Toledo International: China Deterioration Is Imminent
Sep 11Calculating The Intrinsic Value Of Mettler-Toledo International Inc. (NYSE:MTD)
Aug 25What Does Mettler-Toledo International Inc.'s (NYSE:MTD) Share Price Indicate?
Aug 07Mettler-Toledo Stock: Weighing The Potential Here
Jul 10Should You Be Adding Mettler-Toledo International (NYSE:MTD) To Your Watchlist Today?
Jun 26Why Mettler-Toledo International Inc. (NYSE:MTD) Could Be Worth Watching
May 04Here's Why We Think Mettler-Toledo International (NYSE:MTD) Is Well Worth Watching
Mar 25Mettler-Toledo International (NYSE:MTD) Has A Pretty Healthy Balance Sheet
Feb 17Mettler Toledo Q4 2022 Earnings Preview
Feb 08When Should You Buy Mettler-Toledo International Inc. (NYSE:MTD)?
Jan 30Mettler-Toledo: Overvalued Business With Balance Sheet Concerns
Jan 28Should You Be Adding Mettler-Toledo International (NYSE:MTD) To Your Watchlist Today?
Dec 18Mettler-Toledo: Long-Term Value Remains, Retain Buy Rating
Nov 15Calculating The Fair Value Of Mettler-Toledo International Inc. (NYSE:MTD)
Oct 31Is Mettler-Toledo International (NYSE:MTD) Using Too Much Debt?
Oct 13Is There Now An Opportunity In Mettler-Toledo International Inc. (NYSE:MTD)?
Sep 27We Ran A Stock Scan For Earnings Growth And Mettler-Toledo International (NYSE:MTD) Passed With Ease
Sep 12Mettler-Toledo upgraded at Stifel citing opportunity despite macro headwinds
Sep 06Mettler-Toledo International: A Great Science-Oriented Business
Aug 28A Look At The Intrinsic Value Of Mettler-Toledo International Inc. (NYSE:MTD)
Aug 01수익 및 비용 분석
수익 및 비용 분석
Mettler-Toledo International 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
| 날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
|---|---|---|---|---|
| 30 Sep 24 | 3,762 | 796 | 915 | 186 |
| 30 Jun 24 | 3,750 | 786 | 903 | 185 |
| 31 Mar 24 | 3,786 | 778 | 896 | 186 |
| 31 Dec 23 | 3,788 | 789 | 897 | 185 |
| 30 Sep 23 | 3,911 | 870 | 899 | 185 |
| 30 Jun 23 | 3,954 | 889 | 912 | 183 |
| 31 Mar 23 | 3,951 | 887 | 923 | 180 |
| 31 Dec 22 | 3,920 | 873 | 922 | 177 |
| 30 Sep 22 | 3,899 | 838 | 937 | 177 |
| 30 Jun 22 | 3,865 | 821 | 946 | 175 |
| 31 Mar 22 | 3,811 | 793 | 944 | 174 |
| 31 Dec 21 | 3,718 | 769 | 933 | 170 |
| 30 Sep 21 | 3,619 | 754 | 917 | 164 |
| 30 Jun 21 | 3,474 | 712 | 881 | 156 |
| 31 Mar 21 | 3,240 | 654 | 832 | 145 |
| 31 Dec 20 | 3,085 | 603 | 808 | 140 |
| 30 Sep 20 | 2,991 | 579 | 790 | 136 |
| 30 Jun 20 | 2,938 | 547 | 790 | 137 |
| 31 Mar 20 | 2,978 | 547 | 807 | 142 |
| 31 Dec 19 | 3,009 | 561 | 814 | 144 |
| 30 Sep 19 | 2,983 | 550 | 809 | 145 |
| 30 Jun 19 | 2,964 | 547 | 808 | 144 |
| 31 Mar 19 | 2,954 | 531 | 811 | 142 |
| 31 Dec 18 | 2,936 | 513 | 807 | 141 |
| 30 Sep 18 | 2,896 | 408 | 812 | 137 |
| 30 Jun 18 | 2,860 | 387 | 815 | 135 |
| 31 Mar 18 | 2,791 | 377 | 804 | 132 |
| 31 Dec 17 | 2,725 | 376 | 791 | 128 |
| 30 Sep 17 | 2,657 | 437 | 773 | 126 |
| 30 Jun 17 | 2,609 | 433 | 757 | 124 |
| 31 Mar 17 | 2,563 | 411 | 749 | 122 |
| 31 Dec 16 | 2,508 | 384 | 736 | 119 |
| 30 Sep 16 | 2,472 | 370 | 722 | 121 |
| 30 Jun 16 | 2,426 | 357 | 710 | 120 |
| 31 Mar 16 | 2,399 | 355 | 697 | 120 |
| 31 Dec 15 | 2,395 | 353 | 701 | 119 |
| 30 Sep 15 | 2,419 | 351 | 710 | 119 |
| 30 Jun 15 | 2,444 | 347 | 721 | 120 |
| 31 Mar 15 | 2,471 | 343 | 729 | 122 |
| 31 Dec 14 | 2,486 | 338 | 729 | 123 |
| 30 Sep 14 | 2,473 | 327 | 722 | 123 |
| 30 Jun 14 | 2,435 | 317 | 709 | 121 |
| 31 Mar 14 | 2,405 | 312 | 699 | 118 |
| 31 Dec 13 | 2,379 | 306 | 693 | 116 |
양질의 수익: MTD 은 높은 수익을 보유하고 있습니다.
이익 마진 증가: MTD 의 현재 순이익 이익률 (21.1%) 작년보다 낮습니다 (22.2%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: MTD 의 수입은 지난 5년 동안 매년 9.1% 씩 증가했습니다.
성장 가속화: MTD 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.
수익 대 산업: MTD 은 지난 1년 동안 마이너스 수익 성장( -8.5% )을 기록하여 Life Sciences 업계 평균( -4.7% ).
자기자본 수익률
높은 ROE: MTD 의 부채가 자산을 초과하므로 자기자본수익률을 계산하기 어렵습니다.